Accurate and rapid identification of Candida spp. frequently associated with fungemia by using PCR and the microarray-based prove-it sepsis assay

Journal of Clinical Microbiology

Volumn 50, Issue 11, 2012, Pages 3635-3640

  Aittakorpi, Anne ^a   Kuusela, Pentti ^b   Koukila Kähkölä, Pirkko ^b   Vaara, Martti ^b   Petrou, Michael ^c   Gant, Vanya ^d   Mäki, Minna ^a  

^a Mobidiag Ltd   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c CHARING CROSS HOSPITAL   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FUNGAL DNA; NUCLEIC ACID;

ARTICLE; ASSAY; BACTERIAL INFECTION; BLOOD CULTURE; CANDIDA; CONTROLLED STUDY; CULTURE TECHNIQUE; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DNA EXTRACTION; DNA MICROARRAY; FUNGAL DETECTION; FUNGEMIA; FUNGUS CULTURE; FUNGUS IDENTIFICATION; GENE SEQUENCE; INTERMETHOD COMPARISON; MICROARRAY ANALYSIS; MICROARRAY BASED PROVE IT SEPSIS ASSAY; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SEPSIS;

CANDIDA; CANDIDEMIA; HUMANS; MICROARRAY ANALYSIS; MOLECULAR DIAGNOSTIC TECHNIQUES; MYCOLOGY; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TIME FACTORS;

EID: 84867518535     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01461-12     Document Type: Article

References (37)

1. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. 1990. Basic local alignment search tool. J. Mol. Biol. 215:403-410.
2. Arendrup MC, et al. 2008. Semi-national surveillance of fungaemia in Denmark 2004-2006: increasing incidence of fungaemia and numbers of isolates with reduced azole susceptibility. Clin. Microbiol. Infect. 14:487-494. (Pubitemid 351513938)
3. Arendrup MC, et al. 2007. Diagnostics of fungal infections in the Nordic countries: we still need to improve! Scand. J. Infect. Dis. 39:337-343. (Pubitemid 46567385)
4. Bassetti M, et al. 2006. Epidemiological trends in nosocomial candidemia in intensive care. BMC Infect. Dis. 6:21-27.
5. Bouza E, Muñoz P. 2008. Epidemiology of candidemia in intensive care units. Int. J. Antimicrob. Agents 32(Suppl. 2):S87-S91.
6. Bouza E, Perez-Molina J, Munoz P. 1999. Cooperative Group of the European Study Group on Nosocomial Infection: report of ESGNI-001 and ESGNI-002 studies. Bloodstream infections in Europe. Clin. Microbiol. Infect 5(Suppl. 2):2S1-2S12.
7. Campa D, et al. 2008. DNA microarray based on arrayed-primer extension technique for identification of pathogenic fungi responsible for invasive and superficial mycoses. J. Clin. Microbiol. 46:909-915. (Pubitemid 351379978)
8. Chen S, et al. 2006. Australian Candidemia Study: active surveillance for candidemia, Australia. Emerg. Infect. Dis. 12:1508-1516. (Pubitemid 44570891)
9. Chi H-W, et al. 2011. Candida albicans versus non-albicans bloodstream infections: the comparison of risk factors and outcome. J. Microb. Immun. Infect. 44:369-375.
10. CLSI. 2002. User protocol for evaluation of qualitative test performance. Document EP12-A. CLSI, Wayne, PA.
11. Edmond MB, et al. 1999. Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin. Infect. Dis. 29:239-244. (Pubitemid 29380177)
12. Eggimann P, Garbino J, Pittet D. 2003. Epidemiology of Candida species infections in critically ill non-immunosuppressed patients. Lancet Infect. Dis. 3:685-702. (Pubitemid 37345347)
13. Falagas ME, Apostolou KE, Pappas PD. 2006. Attributable mortality of candidemia: a systematic review of matched cohort and case-control studies. Eur. J. Clin. Microbiol. Infect. Dis. 25:419-425. (Pubitemid 44078593)
14. Garey KW, et al. 2006. Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study. Clin. Infect. Dis. 43:25-31. (Pubitemid 43939072)
15. Guery BP, et al. 2009. Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients. Part II. Treatment. Intensive Care Med. 35:206-214.
16. Hajjeh RA, et al. 2004. Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program. J. Clin. Microbiol. 42:1519-1527. (Pubitemid 38500790)
17. Horn DL, et al. 2009. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry. Clin. Infect. Dis. 48:1695-1703.
18. Järvinen AK, Laakso et al. 2009. Rapid identification of bacterial pathogens using a PCR- and microarray-based assay. BMC Microbiol. 9:161. doi:10.1186/1471-2180-9-161.
19. Klouche M, Schröder U. 2008. Rapid methods for diagnosis of bloodstream infections. Clin. Chem. Lab. Med. 46:888-908. (Pubitemid 352000483)
20. Kumar A, et al. 2006. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit. Care Med. 34:1589-1596. (Pubitemid 43810035)
21. Leggieri N, Rida A, François P, Schrenzel J. 2010. Molecular diagnosis of bloodstream infections: planning to (physically) reach the bedside. Curr. Opin. Infect. Dis. 23:311-319.
22. Leinberger DM, Schumacher U, Autenrieth IB, Bachmann TT. 2005. Development of a DNA microarray for detection and identification of fungal pathogens involved in invasive mycoses. J. Clin. Microbiol. 43: 4943-4953. (Pubitemid 41483988)
23. Lu W, et al. 2010. Application of an oligonucleotide microarray-based nano-amplification technique for the detection of fungal pathogens. Clin. Chem. Lab. Med. 48:1507-1514.
24. Miceli MH, Díaz JA, Lee SA. 2011. Emerging opportunistic yeast infections. Lancet Infect. Dis. 11:142-151.
25. Morrell M, Fraser VJ, Kollef MH. 2005. Delaying the empiric treatment of Candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob. Agents Chemother. 49:3640-3645. (Pubitemid 41233011)
26. Morgan J, et al. 2005. Excess mortality, hospital stay, and cost due to candidemia: a case-control study using data from population-based candidemia surveillance. Infect. Control Hosp. Epidemiol. 26:540-547. (Pubitemid 40896144)
27. Muldrew KL. 2009. Molecular diagnostics of infectious diseases. Curr. Opin. Pediatr. 21:102-111.
28. Nucci M, Marr KA. 2005. Emerging fungal diseases. Clin. Infect. Dis. 41:521-526. (Pubitemid 41099648)
29. Olaechea PM, et al. 2004. EPCAN Study Group: economic impact of Candida colonization and Candida infection in the critically ill patient. Eur. J. Clin. Microbiol. Infect. Dis. 23:323-330. (Pubitemid 38669943)
30. Poikonen E, et al. 2009. Nosocomial candidemia in a Finnish tertiary care centre during 1987-2004. Scand. J. Infect. Dis. 41:590-596.
31. Spiess B, et al. 2007. DNA microarray-based detection and identification of fungal pathogens in clinical samples from neutropenic patients. J. Clin. Microbiol. 45:3743-3753. (Pubitemid 350156875)
32. Thompson JD, Higgins DG, Gibson TJ. 1994. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22:4673-4680. (Pubitemid 24354800)
33. Tissari P, et al. 2010. Accurate and rapid identification of bacterial species from positive blood cultures with a DNA-based microarray platform: an observational study. Lancet 375:224-230.
34. Tortorano AM, et al. 2006. Candidaemia in Europe: epidemiology and resistance. Int. J. Antimicrob. Agents 27:359-366.
35. Vincent JL, et al. 2006. Sepsis in European intensive care units: results of the SOAP study. Crit. Care Med. 34:344-353.
36. Wisplinghoff H, et al. 2004. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin. Infect. Dis. 39:309-317. (Erratum, 39:1093; erratum, 40:1077, 2005.)
37. Yoo SM, et al. 2010. DNA microarray-based identification of bacterial and fungal pathogens in bloodstream infections. Mol. Cell. Probes 24:44-52.